Two classes of C5 azido-modified pyrimidine nucleosides were synthesized and explored as radiosensitizers. The 5-azidomethyl-2'-deoxyuridine (AmdU) was prepared from thymidine and converted to its cytosine counterpart (AmdC). The 5-(1-azidovinyl) modified 2'-deoxyuridine (AvdU) and 2'-deoxycytidine (AvdC) were prepared employing regioselective Ag-catalyzed hydroazidation of 5-ethynyl pyrimidine substrates with TMSN3. AmdU and AmdC were converted to 5'-triphosphates AmdUTP and AmdCTP, and incorporated into DNA-fragments via polymerase-catalyzed reaction during DNA replication and base excision repair. Radiation-mediated prehydrated electrons formed in homogeneous aqueous glassy (7.5 M LiCl) systems in the absence of oxygen at 77 K led to site-specific formation of π-type aminyl radicals (RNH•) from AmdU, AmdC, AvdU, and AvdC. The ESR spectral studies and DFT calculations showed RNH• undergo facile conversion to thermodynamically more stable σ-type iminyl radicals, R=N•. For AmdU, conversion of RNH• to R=N• was bimolecular involving α-azidoalkyl radical as intermediate; however, for AvdU, RNH• tautomerized to R=N•. Our work provides the first evidence for the formation of RNH• attached to C5 position of azidopyrimidine nucleoside and its facile conversion to R=N• under reductive environment. These aminyl and iminyl radicals can generate DNA damage via oxidative pathways. The azido-nucleosides were successfully applied as radiosensitizers in EMT6 cancer cells in both hypoxic and normoxic conditions. To explore the generation and reactivity of 2'‑deoxyguanosin-N2-yl radical (dG(N2-H)•) postulated to generate from guanine moiety towards •OH, 2-azido-2'-deoxyinosine (2-N3dI) was prepared by conversion of 2-amino group in protected dG into 2-azido via diazotization with tert-butyl nitrite followed by displacement with azide and deprotection. The investigation of dG(N2-H)• generated from 2-N3dI and its subsequent reactions using ESR will be discussed. Cycloaddition between 5-ethynylpyrimidine or 8-ethynylpurine nucleosides and TMSN3 in the presence of Ag2CO3, CuI, or CuSO4/sodium ascorbate provided N-unsubstituted 1,2,3-triazol-4-yl analogues of the parental DNA bases (i.e. 5-TrzdU, 5‑TrzdC, 8-TrzdA, and 8-TrzdG). These novel triazolyl nucleosides showed excellent fluorescent properties: 8-TrzdA exhibits the highest quantum yield (ΦF) of 44% while 8‑TrzdG had ΦF of 9%. The 5-TrzdU and 5-TrzdC showed a large Stokes shift of ~110 nm. The application of these fluorescent nucleosides to cell imaging and DNA modifications will also be discussed.

Isolé d’une bactérie, Streptomyces alboniger, la puromycine est un nucléoside antibiotique naturel du fait de sa ressemblance structurale avec l’adénosine terminale de l’extrémité 3’ de l’ARNt - aminoacyle. Grâce à cette similarité, cette petite molécule, qui peut diffuser au sein du site A (actif) du ribosome, a la faculté d’inhiber la synthèse protéique. La puromycine est exploitée seulement comme outils pour la recherche fondamentale. En effet, elle n’a encore jamais été exploitée à des fins thérapeutiques chez l’homme car elle est à l’origine de la métabolisation d’un produit toxique. A la suite des travaux du Dr Benoit Michel sur l’analogue nord de la puromycine, l’objectif du projet a été de confectionner un analogue carbocyclique de la puromycine, dont le ribofuranose est bloqué en conformation sud à l’aide d’un pont cyclopropane. L’étape ultérieure serait le test et la comparaison de l’activité dans le ribosome de la molécule obtenue avec celle des analogues précédemment synthétisés. De plus, ces études biochimiques pourraient démontrer si l’équilibre conformationnel du ribofuranose participe ou non à la catalyse du transfert peptidique au même titre que l’hydroxyle 2’ de l’A2451 du peptidyle transférase center. Dans la synthèse énantiosélective de l’analogue sud de la puromycine, la plus grande difficulté vient de l’introduction stéréosélective de l’azote se trouvant en jonction de cycle à 3 et 5 chainons. Dans le but de mettre au point une synthèse la plus courte possible nous avons décidé de former le carbocycle contenant l’azote correctement installé en une seule étape dite de cyclisation intramoléculaire de Kulinkovich – De Meijere. Dans le cas idéal ou la réaction marche convenablement, l’ensemble des 5 centres asymétriques présents de la molécule serait dans la stéréochimie optimale pour la suite de la synthèse. Après de nombreux problèmes, l’objectif directeur du projet a été quelque peu modifié mais est resté l’essai, voir l’optimisation de cette réaction intramoléculaire dans le but de confirmer ou d’infirmer la validité du chemin réactionnel choisi dès le départ / Isolated by a bacterium, Streptomyces Alboniger, the puromycine is a natural nucleoside antibiotic because of its structural similarity with the terminal adenosine of the extremity 3’ of the ARNt-aminoacyle. Thanks to this resemblance, this small molecule, which can spread within the site A of the ribosome, is able to inhibit the protein synthesis. The puromycine is used only as tools for the basic research. Indeed, it was still never run in therapeutics purposes insofar as it is at the origin of the metabolization of a toxic product. Following the work of Dr Benoit Michel on the north analogue of the puromycine, the aim of the project is to synthesize a carbocyclique analogue of the puromycine, whose ribofuranose is blocked in south conformation by means of cyclopropyl bridge. The later step would be the test and the comparison of the activity previously synthesized. Furthermore, these biochemical studies could demonstrate if the conformational equilibrium of the ribofuranose participates or not in the catalysis of the peptide transfer as well as the hydroxyl 2’ of A2451 of the peptidyle transferase center. In the enantioselective synthesis of the south analogue of the puromycine, the highest difficulty comes from the stereoselective introduction of the nitrogen which is found in junction of cycle in 3 and 5 links. With the aim of working out the shortest possible synthesis we decided to form the carbocycle bicyclo[3,1,0]hexane, with the nitrogen correctly set up, in a single step called intramolecular Kulinkovich-De Meijere cyclization. In the ideal case the reaction works suitably, all five asymmetrics contiguous centers of the carbocycle would be obtained in the optimal stereochemistry for next step of the synthesis. After numerous problems, the guiding objective of the project was a little modified but stayed the try and the optimization of this intramolecular reaction with the aim of confirming or invalidating the cogency of the reactive pathway chosen from the beginning

Thesis (Ph.D.)--University of Alberta, 2010. / A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Virology, Medical Microbiology and Immunology. Title from pdf file main screen (viewed on January 10, 2010). Includes bibliographical references.

Isolée d'une bactérie, Streptomyces alboniger, la puromycine est un nucléoside antibiotique naturel présentant une analogie structurale avec l'adénosine terminale de l’extrémité 3’ de l'ARNt aminoacylé. Cette similarité confère à cette molécule la faculté de pouvoir s'insérer dans le site A (actif) du ribosome et d'inhiber la synthèse des protéines. Cependant, du fait de la formation d'un produit toxique lors de sa métabolisation, la puromycine n'a jamais été employée à des fins thérapeutiques chez l'homme. Néanmoins, utilisée en tant qu'outil synthétique, elle a largement contribué à une meilleure compréhension du mécanisme du transfert peptidique. Au travers de cette thèse, six analogues carbobicycliques (deux en série ribo et quatre en série 2'-désoxy), mimant de façon optimale les conformations extrêmes nord ou sud de la puromycine, ont été synthétisés puis testés dans le ribosome. Outre confirmer que la présence d'un groupement 2'-hydroxyle améliorait l'activité inhibitrice, ces expériences in vitro ont apporté une preuve que, dans le site actif, le déplacement de l'équilibre conformationnel du ribofuranose de l'adénosine terminale de l'ARNt aminoacylé – analogue structural de la puromycine – en faveur de son conformère nord pourrait être directement impliqué dans la catalyse ribosomale du transfert peptidique. Par ailleurs, un projet annexe sur le développement de nouveaux antipaludiques potentiels a permis la synthèse, en série xylo, de la puromycine et de son métabolite naturel le puromycine aminonucléoside. Ces composés ont été testés sur les souches 3D7 et Dd2 du parasite Plasmodium falciparum. / Puromycin, a natural antibiotic nucleoside isolated from the bacterium Streptomyces alboniger, has been used to approach and to clear up the understanding of the mechanism of protein biosynthesis. In fact, its structural similarity to the 3' terminal 3'-O-aminoacyl adenylate moiety of aminoacyl-tRNA explains its activity in the ribosomal A site causing the inhibition of the protein synthesis. Since its metabolism generates a toxic product, puromycin cannot be used as therapeutical purposes for humans. During this PhD work, six carbobicyclic analogues of puromycin, conformationally restricted into the northern or southern conformations with the help of a cyclopropane moiety, were synthesized (two ribo-derivatives and four in the 2'-deoxy ribo-series) then tested for pep¬tidyl transfer efficiency in ribosomes. In addition to confirming that the 2'-hydroxyl function is necessary to improve the inhibition properties, these enzymological tests brought an evidence that the conformational switching: southern to northern, occurring in the A site, could directly be involved in the ribosomal catalysis of the peptidyl transfer. Besides, a side project on the elaboration of potential antimalarial compounds provided new xylo-analogues of puromycin and its natural metabolite PAN. These derivatives were tested on the 3D7 and Dd2 strains of the Plasmodium falciparum parasite

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2006. / Härtill 4 uppsatser.

RNA interference (RNAi) in the nematode Caenorhabditis elegans is a type of homology-dependent post-transcriptional gene silencing induced by dsRNA. This dissertation describes the genetic analysis of the RNA interference pathway and inheritance properties associated with this phenomenon. We demonstrate that the RNAi effect can be observed in the progeny of the injected animal for at least two generations. Transmission of the interference effect occurs through a dominant extragenic agent. The wild-type activities of the RNAi pathway genes rde-l and rde-4 are required for the formation of this interfering agent but are not needed for interference thereafter. In contrast, the rde-2 and mut-7 genes are required downstream for interference. These findings provide evidence for germline transmission of an extragenic sequence-specific silencing factor and implicate rde-l and rde-4in the formation of the inherited agent. Other forms of homology-dependent silencing in C. elegansinclude co-suppression and transcriptional silencing of transgenes in the germline. We demonstrate that silencing of a germline transgene can be initiated by injected dsRNA, via the RNAi pathway, and then maintained on a different level. This observation indicates that post-transcriptional and transcriptional silencing of homologous genes could be connected. This dissertation also describes the connection between RNAi and developmental pathways of gene regulation in C. elegans. We show that inactivation of genes related to RNAi pathway genes, a homolog of Drosophila Dicer (dcr-l), and two homologs of rde-1 (alg-l and alg-2) cause heterochronic phenotypes similar to lin-4 and let-7 mutations. Further we show that dcr-l, alg-l, and alg-2 are necessary for the maturation and activity of the lin-4 and let-7small temporal RNAs that regulate stage-specific development. Our findings suggest that a common processing machinery generates guide RNAs that mediate both RNAi and endogenous gene regulation. Finally, this study illustrates the detection of small interfering RNAs (siRNAs), intermediates in the RNAi process, and describes requirements for their accumulation. We show that, in the course of RNAi induced by feeding dsRNA, C. elegans accumulate only siRNAs complementary to the target gene. This accumulation depends on the presence of the target sequence and requires activities of several RNAi-pathway genes. We show that selective retention or amplification of RNAi-active molecules can create a reservoir of memory antisense siRNAs that prevent future expression of the genes with complementary sequence. This suggests a parallel at the molecular level with the clonal selection of antibody forming cells and in the vertebrate immune system.

It has been well documented that mRNA is associated with the cytoskeleton, and that this relationship is involved in translation and mRNA sorting. The molecular components involved in the attachment of mRNA to the cytoskeleton are only poorly understood. The objective of this thesis was to directly visualize the interaction of mRNA with the cytoskeleton, with sufficient resolution to identify the filament systems and structures involved. This work required the development of novel in situ hybridization methods for use with electron microscopy. This allowed resolution to visualize single mRNA molecules and individual filaments. The development of a silver enhancement methodology for both the light and electron microscopic detection of biotinated oligo-dT probes permitted a synoptic view of the intracellular distribution of poly(A) mRNA. At the light microscope, the distribution of poly(A) mRNA did not resemble the individual distribution patterns of microfilaments, intermediate filaments or microtubules. Ultrastructural examination revealed that poly(A) mRNA was not uniformly distributed along cytoskeletal filaments, but clustered at their intersections. The composition of these mRNA containing structures was investigated by both morphologic and in situ hybridization analysis using antibodies to cytoskeletal proteins. In thin sections, polysomes were observed attached to both microfilaments and intermediate filaments. To permit the simultaneous detection of oligo-dT hybridization and specific cytoskeletal proteins, a double labelling method using colloidal gold conjugated antibodies was developed. The majority of poly(A) mRNA was associated with the actin cytoskeleton, with 72% of the hybridization localized within 5nm of a labelled microfilament. Within the actin cytoskeleton, poly(A) mRNA was localized to intersections of orthogonal networks. Greater than 50% of poly(A) colocalized with the actin crosslinking proteins, filamin and α-actinin, but not vinculin. A significant amount of poly(A) mRNA was found to be associated with intermediate filaments. The double label gold analysis demonstrated that 33% of the hybridization signal localized within 5nm of labelled vimentin filaments. Prior disorganization of the actin cytoskeleton using cytochalasin did not disrupt the association of mRNA with vimentin. These observations are consistent with our morphologic results of polysome-intermediate filament associations, and indicate that microfilaments are not the only filament system to which mRNA is bound. Furthermore, a small amount of hybridization signal (12%) consistently was observed along microtubules, providing an additional cytoskeletal network to distribute mRNA. To further characterize the spatial organization of mRNA within the cytoskeleton, ultrastructural methods were developed to directly visualize individual mRNA molecules. First, oligonucleotide probes chemically modified with a single hapten and directly conjugated primary reagents were used to permit detection of an individual hybridized probe molecule by a single gold particle. Second, biotin and digoxigenin labelled oligonucleotide probes were used to simultaneously visualize the intermolecular and intramolecular relationships of two nucleic acid sequences. Third, reverse transcriptase was used to extend hybridized primers in situ which permitted visualization of the poly(A) sequence concomittant with the conformation of an mRNA molecule. These methods have permitted analysis of how single mRNA molecules may be positioned with respect to each other within the cytoskeleton. The ultrastructural visualization of mRNA within its structural environment has demonstrated heterogeneous interactions with the cytoskeleton. Future work will be needed to further characterize the mechanism of mRNA attachment. The proteins which bridge nucleic acid sequences to specific intersections can be identified. It will be interesting to learn how the identified mRNA-cytoskeletal interactions might be involved in the regulation of both mRNA translation and intracellular location. Lastly, and perhaps the most challenging goal, is to investigate whether the identified mRNA-cytoskeletal interactions are used by the cell to influence its own shape, polarity and architecture.

This thesis examines the structure and regulated expression of the gene encoding the neuroendocrine peptides neurotensin and neuromedin N (NT/N gene). Previous studies have shown that expression of NT/N mRNA and NT peptide in PC12 cells are strictly dependent on simultaneous exposure to combinations of nerve growth factor (NGF), glucocorticoids, activators of adenylate cyclase, and lithium ion. My objective was to characterize the cis-regulatory DNA sequences involved in regulated expression of this gene. The initial focus of this study was an analysis of the structure, tissue-specific expression, and exon evolution of the rat NT/N gene. Nucleotide sequence comparisons between the rat gene and the canine and bovine cDNA sequences indicated that the predicted structure of a 170 amino acid precursor protein is highly conserved. Furthermore, the close similarity between the two cDNAs suggested that identical precursor proteins are expressed in neural and endocrine tissues. RNA analysis revealed that the gene is transcribed to yield two distinct mRNAs, 1.0 kb and 1.5 kb in size. The two mRNA species differ only in the size of their 3' untranslated regions. Interestingly, the smaller mRNA is predominant in the gastrointestinal tract, while both mRNAs are equally abundant in all neural tissues examined, except the cerebellum, where no expression was observed. Transient transfection assays were used to delineate the rat NT/N gene cis-regulatory DNA sequences. Progressive deletion of the NT/N 5' flanking region revealed that sequences between -216 and +56 of the NT/N gene are sufficient to confer the full spectrum of responses of the endogenous gene to either of two reporter genes. A detailed mutational analysis of the NT/N control region indicated that it is composed of an array of inducible cis-regulatory elements, including an AP-1 site, two cAMP-responsive elements (CREs), and a glucocorticoid-responsive element (GRE). Specific mutations to the AP-1 site and either CRE suggested that these elements are functionally interdependent. I propose that this array of cis-regulatory sequences in the NT/N transcriptional control region serves to integrate multiple environmental stimuli into a unified transcriptional response. To further examine the role of the AP-1 site and CREs in the NT/N promoter, reporter genes containing either a single or multiple AP-1 or CRE sites were expressed in PC12 cells and protein kinase A-deficient PC12 cells treated with forskolin, NGF, and lithium, either individually, or in combination. The results indicated that lithium and NGF markedly activate promoters containing multiple AP-1 sites, but not a single site, and that these effects were additive. Both agents potentiated forskolin-induced activation of promoters containing a single or multiple CREs, but had no effect, individually. Also, in contrast to the activation of multiple AP-1 sites by lithium and NGF, activation of the NT/N promoter and promoters containing CREs is absolutely dependent on protein kinase A activity. These results suggested that promoters containing multiple AP-1 sites, or a single AP-1 site in the context of nearby active CREs, are selectively activated by lithium and NGF in PC12 cells. Based on the results of this thesis I have proposed a model to account for the complex transcriptional regulation of the NT/N gene in PC12 cells. I have also addressed the relevance of these findings to the mechanisms of phenotypic plasticity of embryonic neural crest cells, NGF-induced neuronal differentiation, and the pharmacological actions of lithium.

6-(p-Hydroxyphenylhydrazino) uracil (H2-HPUra) is a selective and potent inhibitor of the replication-specific DNA polymerase III (pol III) of Gram+ bacteria such as Bacillus subtilis. Although a pyrimidine, H2-HPUra derives its inhibitory activity from its specific capacity to mimic the purine nucleotide, dGTP. The project described in this thesis dissertation involves the use of H2-HPUra-like inhibitors to probe the structure and function of the pol III active site. It consists of two separate problems which are summarized below. Production of a potent bona fide dGTP form of inhibitor. A method was devised to successfully convert the H2-HPUra inhibitor prototype to a bona fide purine, using N2-benzyl guanine as the basis. Structure-activity relationships of benzyl guanines carrying a variety of substituents on the aryl ring identified N2-(3,4-dichlorobenzyl) guanine (DCBG) as a compound equivalent to H2-HPUra with respect to potency and inhibitor mechanism. DCBdGTP, the 2'-deoxyribonucleoside 5'-triphosphate form of DCBG, was synthesized and characterized with respect to its action on wild-type and mutant forms of pol III. DCBdGTP acted on pol III by the characteristic inhibitor mechanism and formally occupied the dNTP binding site with a fit which permitted its polymerization. The latter experiment identified the site for the binding of the inhibitor's aryl moiety as a distinct site located at a distance of approximately 6-7 Å from the base-paired 2-NH group of a bound dGTP. Attempt to covalently label amino acid residue 1175, a putative participant in inhibitor binding. Azp-12, a point mutation of serine 1175, yields a form of pol III whose inhibitior sensitivity varies specifically as a function of the composition of the para substituent of the inhibitor's aryl ring. On the basis of the latter behavior, residue 1175 was hypothesized to be a residue directly involved in the binding of the inhibitor's aryl moiety. To test this hypothesis, residue 1175 was specifically mutated to either cysteine or lysine, each of which presents a side chain amenable to covalent bond formation with appropriately reactive inhibitor forms. Of the two mutant pol III forms, only the cysteine form (pol III-cys) was catalytically active. The kinetic properties and inhibitor sensitivity profile of pol III-cys identified it as a target suitable for potentially irreversible inhibitor forms containing the following groups in the meta position of the aryl ring: -CH2Br, -CH2C1, and -CH2SH. None of the several inhibitors tested selectively or irreversibly inactivated pol III-cys. Possible bases for the failure of this group of inhibitors and for the redesign of more useful covalently reactive inhibitor forms are considered.

In diverse eukaryotic organisms, double-stranded RNA (dsRNA) induces robust silencing of cellular RNA cognate to either strand of the input dsRNA; a phenomenon now known as RNA interference (RNAi). Within the RNAi pathway, small, 21 nucleotide (nt) duplexed RNA, dubbed small interfering RNAs (siRNAs), derived from the longer input dsRNA, guide the RNA induced silencing complex (RISC) to destroy its target RNA. Due to its ability to silence virtually any gene, whether endogenous or exogenous, in a variety of model organisms and systems, RNAi has become a valuable laboratory tool, and is even being heralded as a potential therapy for an array of human diseases. In order to understand this complex and unique pathway, we have undertaken the biochemical characterization of RNAi in the model insect, Drosophila melanogaster. To begin, we investigated the role of ATP in the RNAi pathway. Our data reveal several ATP-dependent steps and suggest that the RNAi reaction comprises as least five sequential stages: ATP-dependent processing of double-stranded RNA into siRNAs, ATP-independent incorporation of siRNAs into an inactive ~360 kDa protein/RNA complex, ATP-dependent unwinding of the siRNA duplex to generate an active complex, ATP-dependent activation of RISC following siRNA unwinding, and ATP-independent recognition and cleavage of the RNA target. In addition, ATP is used to maintain 5´ phosphates on siRNAs, and only siRNAs with these characteristic 5´ phosphates gain entry into the RNAi pathway. Next, we determined that RISC programmed exogenously with an siRNA, like that programmed endogenously with microRNAs (miRNAs), is an enzyme. However, while RISC behaves like a classical Michaelis-Menten enzyme in the presence of ATP, without ATP, multiple rounds of catalysis are limited by release of RISC-produced cleavage products. Kinetic analysis of RISC suggests that different regions of the siRNA play distinct roles in the cycle of target recognition, cleavage and product release. Bases near the siRNA 5´ end disproportionately contribute to target RNA-binding energy, whereas base pairs formed by the central and 3´ region of the siRNA provide helical geometry required for catalysis. Lastly, the position of the scissile phosphate is determined during RISC assembly, before the siRNA encounters its RNA target. In the course of performing the kinetic assessment of RISC, we observed that when siRNAs are designed with regard to 'functional asymmetry' (by unpairing the 5´ terminal nucleotide of the siRNA's guide strand, i.e. the strand anti-sense to the target RNA), not all of the RISC formed was active for target cleavage. We observed, somewhat paradoxically, that increased siRNA unwinding and subsequent accumulation of single-stranded RNA into RISC led to reduced levels of active RISC formation. This inactive RISC did not act as a competitor for the active fraction. In order to characterize this non-cleaving complex, we performed a series of protein-siRNA photo-crosslinking assays. From these assays we found that thermodynamic stability and termini structure plays a role in determining which proteins an siRNA will associate with, and how association occurs. Furthermore, we have found, by means of the photo-crosslinking assays, that siRNAs commingle with components of the miRNA pathway, particularly Ago1, suggesting overlapping functions or crosstalk for factors thought to be involved in separate, distinct pathways.